Larson Financial Group’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
Other funds holding BEAM
KCM
Larson Financial Group's BEAM Position: Q3 2026 in Review
Larson Financial Group reduced its Beam Therapeutics (BEAM) stake by 7.2% in Q3 2026, selling an estimated $6.51K and leaving 3,000 shares worth $73.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1403.
Larson Financial Group first reported a position in BEAM in Q1 2021 and has held it in 23 quarters since. The position peaked at $111K in Q2 2026. 264 funds tracked by Wall St. Rank hold BEAM as of Q3 2026.
- Larson Financial Group held 3,000 shares of Beam Therapeutics worth $73.4K as of Q3 2026.
- Larson Financial Group sold 234 Beam Therapeutics shares in Q3 2026, an estimated $6.51K.
- Beam Therapeutics made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #1403 holding.
- Larson Financial Group first reported a position in Beam Therapeutics in Q1 2021 and has held it in 23 quarters since.
- Larson Financial Group's Beam Therapeutics position peaked at $111K in Q2 2026.
- 264 funds tracked by Wall St. Rank held Beam Therapeutics as of Q3 2026.
Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.